Valeo Financial Advisors’s Tenax Therapeutics TENX Stock Holding History

Valeo Financial Advisors’s Portfolio TENX Stock Details TENX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3	Closed	-$10K	–	1689
2021 Q1	$10K	Buy	+3	New	+$10.7K	﹤0.01%	1367

Other funds holding TENX

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FWP

FAS Wealth Partners Leawood, Kansas $1.61B AUM 19.97% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Valeo Financial Advisors's TENX Position: Q2 2021 in Review

Valeo Financial Advisors sold out of Tenax Therapeutics (TENX) in Q2 2021, closing a stake of 3 shares — an estimated $10K sold.

Valeo Financial Advisors first reported a position in TENX in Q1 2021 and held it in 1 quarter. The position peaked at $10K in Q1 2021. 15 funds tracked by Wall St. Rank hold TENX as of Q2 2021.

Valeo Financial Advisors reported no remaining Tenax Therapeutics position as of Q2 2021 after selling out during the quarter.
Valeo Financial Advisors sold 3 Tenax Therapeutics shares in Q2 2021, an estimated $10K.
Valeo Financial Advisors first reported a position in Tenax Therapeutics in Q1 2021 and held it in 1 quarter.
Valeo Financial Advisors's Tenax Therapeutics position peaked at $10K in Q1 2021.
15 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2021.

Based on Valeo Financial Advisors's 13F filing for Q2 2021, filed 22 Jul 2021.